CCNG2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.321770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.588440E-01
Normal-vs-Stage2
1.604600E-01
Normal-vs-Stage3
1.552000E-01
Normal-vs-Stage4
4.688400E-01
Stage1-vs-Stage2
5.108400E-01
Stage1-vs-Stage3
6.441200E-01
Stage1-vs-Stage4
6.433600E-01
Stage2-vs-Stage3
3.367000E-01
Stage2-vs-Stage4
9.571600E-01
Stage3-vs-Stage4
4.928600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.422150E-01
Normal-vs-AfricanAmerican
1.576370E-01
Normal-vs-Asian
8.503700E-02
Caucasian-vs-AfricanAmerican
6.089000E-01
Caucasian-vs-Asian
2.796200E-01
AfricanAmerican-vs-Asian
7.668000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.176990E-01
Normal-vs-Female
1.657620E-01
Male-vs-Female
8.320400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.947400E-01
Normal-vs-Age(41-60Yrs)
4.672200E-01
Normal-vs-Age(61-80Yrs)
4.737500E-02
Normal-vs-Age(81-100Yrs)
8.827800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.450200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.690800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.375200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.161900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.605700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.300600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.956420E-01
Normal-vs-Daily Drinker
2.427800E-01
Normal-vs-Weekly Drinker
4.734200E-02
Normal-vs-Occasional Drinker
5.080000E-01
Normal-vs-Social Drinker
1.000250E-01
Non Drinker-vs-Daily Drinker
8.103600E-01
Non Drinker-vs-Weekly Drinker
3.977600E-01
Non Drinker-vs-Occasional Drinker
2.568600E-01
Non Drinker-vs-Social Drinker
9.624200E-01
Daily Drinker-vs-Weekly Drinker
2.953600E-01
Daily Drinker-vs-Occasional Drinker
3.863000E-01
Daily Drinker-vs-Social Drinker
7.813200E-01
Weekly Drinker-vs-Occasional Drinker
7.532500E-02
Weekly Drinker-vs-Social Drinker
3.382400E-01
Occasional Drinker-vs-Social Drinker
2.556000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.240210E-01
Normal-vs-Grade 2
3.820400E-02
Normal-vs-Grade 3
3.785800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.669800E-02
Grade 1-vs-Grade 3
3.535900E-03
Grade 1-vs-Grade 4
1.240210E-01
Grade 2-vs-Grade 3
1.211430E-01
Grade 2-vs-Grade 4
3.820400E-02
Grade 3-vs-Grade 4
3.785800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.306570E-01
Normal-vs-NonDiabetic
1.161370E-01
Diabetic-vs-NonDiabetic
8.421600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.758200E-01
Normal-vs-NoPancreatitis
9.308000E-02
Pancreatitis-vs-NoPancreatitis
3.381000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.140040E-01
Normal-vs-N1
1.633030E-01
N0-vs-N1
4.558200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.196800E-01
Normal-vs-TP53-NonMutant
6.679500E-02
TP53-Mutant-vs-TP53-NonMutant
2.459100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
